Spruce Biosciences, Inc. Increase (Decrease) in Other Operating Assets
Spruce Biosciences, Inc. (SPRB) reported Increase (Decrease) in Other Operating Assets of $769.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-12
- Spruce Biosciences, Inc. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was $833.00K.
- Spruce Biosciences, Inc. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was -$64.00K.
- Spruce Biosciences, Inc. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was $0.00.
- Spruce Biosciences, Inc. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was $0.00.
- Spruce Biosciences, Inc. increase (decrease) in other operating assets for fiscal 2025 was $0.00.
- Spruce Biosciences, Inc. increase (decrease) in other operating assets for fiscal 2024 was -$494.00K.
- Spruce Biosciences, Inc. increase (decrease) in other operating assets for fiscal 2023 was -$96.00K.
- Spruce Biosciences, Inc. increase (decrease) in other operating assets for fiscal 2022 was -$90.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $833.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $769.00K 10-Q · filed 2026-08-12 | $769.00K derived: sum of 3 quarters · filed 2026-08-12 | $769.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$64.00K 10-Q · filed 2026-05-13 | -$64.00K derived: sum of 2 quarters · filed 2026-05-13 | -$64.00K derived: sum of 3 quarters · filed 2026-05-13 | -$64.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | $0.00 derived: sum of 3 quarters · filed 2026-08-12 | $0.00 10-K · filed 2026-03-09 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2026-08-12 | $0.00 10-Q · filed 2025-11-10 | -$409.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 | -$409.00K derived: sum of 3 quarters · filed 2026-08-12 | -$421.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-13 | -$409.00K derived: sum of 2 quarters · filed 2026-05-13 | -$421.00K derived: sum of 3 quarters · filed 2026-05-13 | -$420.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$409.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$421.00K derived: sum of 2 quarters · filed 2026-03-09 | -$420.00K derived: sum of 3 quarters · filed 2026-03-09 | -$494.00K 10-K · filed 2026-03-09 |
| 2024-09-30 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$11.00K derived: sum of 2 quarters · filed 2025-11-10 | -$85.00K 10-Q · filed 2025-11-10 | -$71.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$73.00K 10-Q · filed 2025-08-14 | -$59.00K derived: sum of 3 quarters · filed 2025-08-14 | -$24.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$74.00K 10-Q · filed 2025-05-06 | -$60.00K derived: sum of 2 quarters · filed 2025-05-06 | -$25.00K derived: sum of 3 quarters · filed 2025-05-06 | -$13.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $49.00K derived: sum of 2 quarters · filed 2025-04-15 | $61.00K derived: sum of 3 quarters · filed 2025-04-15 | -$96.00K 10-K · filed 2025-04-15 |
| 2023-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $47.00K derived: sum of 2 quarters · filed 2024-11-12 | -$110.00K 10-Q · filed 2024-11-12 | -$122.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$145.00K 10-Q · filed 2024-08-12 | -$157.00K derived: sum of 3 quarters · filed 2024-08-12 | -$208.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$157.00K 10-Q · filed 2024-05-13 | -$169.00K derived: sum of 2 quarters · filed 2024-05-13 | -$220.00K derived: sum of 3 quarters · filed 2024-05-13 | -$220.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | -$63.00K derived: sum of 2 quarters · filed 2024-03-18 | -$63.00K derived: sum of 3 quarters · filed 2024-03-18 | -$90.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | -$51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$51.00K derived: sum of 2 quarters · filed 2023-11-13 | -$78.00K 10-Q · filed 2023-11-13 | -$144.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$27.00K 10-Q · filed 2023-08-14 | -$93.00K derived: sum of 3 quarters · filed 2023-08-14 | -$193.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$27.00K 10-Q · filed 2023-05-15 | -$93.00K derived: sum of 2 quarters · filed 2023-05-15 | -$193.00K derived: sum of 3 quarters · filed 2023-05-15 | -$208.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$166.00K derived: sum of 2 quarters · filed 2023-03-16 | -$181.00K derived: sum of 3 quarters · filed 2023-03-16 | -$197.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$115.00K derived: sum of 2 quarters · filed 2022-11-10 | -$131.00K 10-Q · filed 2022-11-10 | -$286.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$31.00K 10-Q · filed 2022-08-10 | -$186.00K derived: sum of 3 quarters · filed 2022-08-10 | $11.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | -$16.00K 10-Q · filed 2022-05-11 | -$171.00K derived: sum of 2 quarters · filed 2022-05-11 | $26.00K derived: sum of 3 quarters · filed 2022-05-11 | $26.00K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | -$155.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $42.00K derived: sum of 2 quarters · filed 2022-03-14 | $42.00K derived: sum of 3 quarters · filed 2022-03-14 | $6.00K 10-K · filed 2022-03-14 |
| 2020-09-30 | $197.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $197.00K derived: sum of 2 quarters · filed 2021-11-15 | $161.00K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$36.00K 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | -$36.00K 10-Q · filed 2021-05-12 | |||
| 2019-12-31 | $36.00K 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |